Voythos, founded in 2021, is a pioneering AI informatics company focused on healthcare innovations, specifically targeting aortic disease. The company's slogan, "Transforming aortic disease with predictive intelligence," underscores their mission to develop cutting-edge multimodal machine learning models. These models aim to predict and prevent life-threatening complications, enabling earlier intervention by cardiovascular surgeons, thereby saving lives and limbs.
Headquartered in the United States, Voythos is situated at the intersection of AI, Health Care, and Clean Energy industries. In 2022, they secured a $180.00K Pre Seed Round investment from renowned investors such as Forum Ventures and Right Side Capital Management. This financial backing highlights investor confidence in Voythos’s innovative solutions and potential for substantial impacts in cardiology.